medical device content marketing
Three Keys to B2B Content Marketing for Complex Sales
by Joshua Schneck | October 10, 2013
There are three keys to B2B content marketing for complex sales – corporate law firm marketing, healthcare information technology products and services, medical device, B2B food manufacturing and other B2B products and services. These are sales with longer sales lead times and higher price tags, and rely on direct meetings and contacts to build relationships and close the deal. As a Minneapolis B2B content marketing agency, we’ve always matched PR, marketing and other services to the actual sales process of our clients. With content marketing, the opportunities for engaging prospects and clients have become better – including social media and analytic methods. We’ve found that three keys to B2B content marketing for complex sales are:
1. Have a documented content marketing strategy.
2. Match content marketing to the sales process.
3. Measure and improve the strategy as needed.
Documented content marketing strategies are more successful
According to research sponsored by Brightcove, the marketers who reported having a documented content marketing plan were more likely to say they were effective – 66%, than those who did not have a documented content marketing plan – 11%. I’d make some allowance for selection bias here, as those who invest the time and resources in developing a documented strategy might be inclined to score their efforts higher, but the point is that serious marketing efforts generally stem from a fair amount of analysis and planning. Unfortunately, content marketing is too often the flavor of the month and done on a piecemeal basis, without a formal strategy or plan.
What’s in an effective, documented content marketing strategy? At a minimum, it should set out clear goals, identify team members (including outside resources) and responsibilities, contain a SWOT analysis, and lay out basic tactics and timetable. Ideally, it should also include a description and analysis of your sales and marketing process and spell out how content marketing will support – and in some cases, lead – that process. In addition, it should identify prime topics to focus on – topics that of are interest to your prospects and customers in ways that help build a case for ultimately buying your product or service. For example, a company trying to sell software to drive efficiencies in the hospital emergency department might publish white papers, case studies, blog entries, etc. on revenue, margin, cost and quality issues for hospitals. A law firm selling intellectual property services might focus on content that explores the implication of new laws, rulings, treaties and technologies that present challenges and opportunities to their clients and prospects.
Match B2B content marketing to the sales process
As Joel York illustrates with this graphic in his excellent blog, the B2B buyer enters a “fuzzy funnel” that is built on content marketing and social media. Much of the old “solution selling” has already occurred before a sales rep has spoken with the customer. As Brent Adamson, Mathew Dixon and Nicholas Toman point out in their Harvard Business Review article:
“A recent Corporate Executive Board study of more than 1,400 B2B customers found that those customers completed, on average, nearly 60% of a typical purchasing decision—researching solutions, ranking options, setting requirements, benchmarking pricing, and so on—before even having a conversation with a supplier. In this world the celebrated ‘solution sales rep’ can be more of an annoyance than an asset. Customers in an array of industries, from IT to insurance to business process outsourcing, are often way ahead of the salespeople who are ‘helping’ them.”
The good news here is that the right mix of content marketing, matched to the actual sales process, will support your sales effort and boost inbound marketing. Careful attention to relevant government or industry standard setting developments, major trade shows, LinkedIn discussion groups, pain points and other factors will provide guidance on the mix and timing of content marketing initiatives (set out in the the documented strategy, of course). We had a patent law firm client where we focused on a key change in an obscure part of IP law. Two weeks after publishing a document on the subject, a prospect contacted the author and signed up for more than $1,000,000 in legal services.
Measure and improve the strategy as needed
In the old days of marketing, you did your best analysis, conducted effectiveness research of varying value, and prayed a lot. Today, the analytics permit fine and real time measurement of everything you’re doing in content marketing. Are you not currently measuring? You’re not alone. Only 15% of attendees as a recent content marketing conference reported good measurement. Yet, the tools are there already, via Google, your website, Twitter, etc. By tracking page views, downloads, shares, guest postings, lead generation and impact on sales, you can measure impact and ROI and make adjustments in real time. The important thing is to measure things that are critical to your actual sales process, and that offer insights of value. There’s no cookie cutter approach here. Customize it.
In addition, listen to what prospects and customers are saying in their posts, Tweets, blogs and to your sales people. If Regulation “Q” is on everyone’s mind, it makes sense to address content to that concern. With good measurement tools, and a close ear to what prospects and customer are saying, your content marketing will be relevant, timely, and most importantly, effective.
Questions? Comments?
We’d love to hear you questions or comments. Please contact me directly. As a Minneapolis B2B content marketing agency, we’re eager to keep learning and carrying on a dialogue with like-minded professionals.
Can healthcare PR be a crime?
by Joshua Schneck | September 24, 2013
Can healthcare PR be a crime? In the case of ex-InterMune CEO W. Scott Harkonen, the answer is yes – according to the U.S. government, a Federal jury and the Ninth Circuit Court of Appeals. David Brown writes in The Washington Post about how Harkonen was convicted for issuing a press release that, according to the U.S. government, willfully overstated the benefits of a drug made by his company.
InterMune is a public company focused on pulmonary and orphan fibrotic diseases. It markets a medicine for idiopathic pulmonary fibrosis (IPF) and is in product development and clinical trials on other drugs.
No Factual Errors
According to Brown’s article, there were no factual errors in the press release in question. It was the interpretation of the facts that was deemed criminal. This raises troubling questions for a Minneapolis healthcare PR firm like ours, and our clients. When does promoting a point of view become a crime?
From the Post article:
“If you applied this rule to scientists, a sizable proportion of them might be in jail today,” said Steven N. Goodman, a pediatrician and biostatistician at Stanford University who submitted a statement supporting Harkonen’s appeal. “The courts don’t quite realize the significance of what is in front of them or the furor that might erupt if this kooky precedent is allowed to stand.”
Ruling a word of caution to a Minneapolis healthcare PR firm
This ruling is a word of caution to a Minneapolis healthcare PR firm that works in healthcare PR and healthcare content marketing. Can healthcare PR be a crime? It can in some cases, but there is a free speech issue here that needs to be thought through carefully.
Ultimately, it gets down to what patients are entitled to know. They shouldn’t be deceived, obviously, but should they be prevented from knowing a company’s interpretation of research facts? I don’t claim to have the answer, but it’s a question worth asking.
Bringing clarity to medical device PR
by Joshua Schneck | September 23, 2013
Bringing clarity to medical device PR is a long standing goal of this Minneapolis healthcare PR firm.
MR Instruments is a producer of high-resonance MRI technology and developed the medical technology industry’s first 3T (Tesla) MRI coils for the most demanding MRI applications. The clarity of image MR Instruments helps produce for physicians was our inspiration for bringing clarity to MRI’s target audiences: MRI manufacturing companies, MRI users and buyers and key influencers.
MR Instruments hired Snow to increase visibility of this new technology and officially launch its flagship product at the RSNA Conference in Chicago. Snow Communications drew on its deep expertise and experience in medical device PR and medical device content marketing to bring about good results for MRI.
For more details, please see the case study.